A Research Study Looking at New Protein-based Tablets in Healthy Men - Oral Formulation IV
← catalyst calendarSponsored by Novo Nordisk A/S (industry) · NVO — their whole pipeline →.
Phase
Phase 1
Status
Completed
Study type
Interventional
Design
Randomized · None · Treatment
Enrollment
90actual
Sites
1
Country
Canada
Every value on this page is a field the sponsor filed with ClinicalTrials.gov, reproduced. Dates are their own estimates, revised as a study runs, unless the registry marks them actual. sources →
Source: ClinicalTrials.gov, retrieved 2026-08-19
Dates
each axis at the precision it was filed, with the registry's own basis| Date | Filed | Basis | What it is |
|---|---|---|---|
| Start | 2024-10-15 | actual | When the study began enrolling |
| Primary completion | 2025-07-10 | actual | The date the last participant is measured for the primary outcome — the readout window |
| Study completion | 2025-08-13 | actual | The whole study's end, after follow-up |
| First posted | 2024-10-15 | actual | When this record first appeared on the registry |
| Results posted | — | When the sponsor posted results to the registry | |
| Record updated | 2025-10-20 | actual | The sponsor's own last edit to this record — every projection above is as current as this date |
What it studies
Condition
- Healthy Volunteers Type 2 Diabetes
Interventions
- Drug: Semaglutide B
- Drug: Semaglutide J
- Drug: Semaglutide L
- Drug: Semaglutide M
- Drug: Semaglutide N
Primary outcomes
what the primary-completion date above is the date OFAdjusted AUC(sema); adjusted area under the semaglutide plasma concentration-time curve
measured From 0 to 24 hours after dosing on Days 122 and 132.
Adjusted Cmax,(sema); adjusted maximum observed semaglutide plasma concentration
measured From 0 to 24 hours after dosing on Days 122 and 132.
Adjusted tmax,sema; time to adjusted maximum observed semaglutide plasma concentration
measured From 0 to 24 hours after dosing on Days 122 and 132.
t½,sema; the terminal half-life of semaglutide
measured From 0 to 840 hours after dosing on Day 132.
Permalink · NVO's whole pipeline · Catalyst calendar · Every registered study · What changed